CD8A and cancer: The FAP+CAFs were discovered to utilize the CXCR4/CXCL-12 axis to effectively exclude CD8+ T cells from the region containing cancer cells by releasing CXCL-12, ultimately preventing the CD8+ T cells from reaching the TME [270].